Moderna Wuhan pneumonia vaccine uses mRNA technology.

Vaccine diagram.

(AFP file photo)

[Reporter Yang Yuanting/Taipei Report] Moderna has achieved great success in developing the Wuhan pneumonia (new coronavirus disease, COVID-19) vaccine. Today, it announced the establishment of a branch in Taiwan, and Moderna decided to develop mRNA vaccines The key figure in this is Eric Huang, a Taiwanese scientist. He will give a speech at Chenggong University on December 23 with Weng Qihui, the former dean of the Chinese Academy of Sciences who developed a broad-spectrum pneumonia mRNA vaccine. This is also his first public speech in Taiwan.

Huang Yiqun immigrated to the United States with his parents when he was 14 years old. He is currently the general manager and scientific chief of Moderna Genomics, a subsidiary of Moderna. His resume shows that he has a Ph.D. in molecular biology and medical parasitology, as well as an MBA degree. Speak fluent Chinese.

Please read on...

After the outbreak of pneumonia in Wuhan, the New Venture Labs team led by Huang Yiqun was a key figure in enabling Moderna to develop mRNA vaccines. Lun.

One of five scientists awarded the Warren Alpert Prize for mRNA vaccines.

It is understood that Huang Yiqun and Weng Qihui will give speeches on the same stage at Chengdu University this month. The topics of the speeches are all about mRNA vaccines. This will be the first public speech for this Taiwanese scientist in Taiwan.

Related news please see:

Please click here for "Wuhan Pneumonia Zone", for more information, you can grasp it first-hand.

The key figure in Moderna's decision to develop an mRNA vaccine is Eric Huang, a Taiwanese scientist from Taiwan.

(Reposted from Harvard University website)